Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,009 across all filing types
Latest filing 2018-04-11 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
独立董事关于董事变更暨提名董事候选人的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion on a board change and nomination of a director candidate. It references compliance with listing rules and governance standards, and it is related to board/management changes. The document is short (499 characters) and focuses on board nomination, not a full report or announcement of voting results. Therefore, it fits best under Board/Management Information (MANG).
2018-04-11 Chinese
独立董事关于聘请2018年度审计机构的独立意见
Audit Report / Information Classification · 95% confidence The document is an independent director's opinion regarding the appointment of the 2018 annual audit firm for the company. It references regulatory rules and governance standards related to audit appointments and discusses the continuation of the audit firm for the 2018 fiscal year. The document does not contain actual financial statements or detailed audit results but is an opinion on the audit firm appointment. This fits the category of Audit Report / Information (AR), which includes standalone audit reports and related information excluding full annual reports. The document length is short and focused on audit firm appointment, not a full annual report or certification. Therefore, the classification is AR with high confidence. FY 2018
2018-04-11 Chinese
关于2017年度利润分配预案的公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the 2017 annual profit distribution plan of the company, including details about no cash dividends, no bonus shares, and no capital reserve conversion to shares. It includes opinions from the board of directors, independent directors, and the supervisory board, and mentions that the plan will be submitted to the annual shareholders' meeting for approval. The document is relatively short (1352 characters) and focuses on the profit distribution proposal rather than the full annual report or financial statements. This type of announcement fits the category of Notice of Dividend Amount (DIV), as it relates to dividend distribution plans and shareholder information about profit allocation.
2018-04-11 Chinese
2017年度监事会工作报告
Management Reports Classification · 95% confidence The document is titled as the "2017年度监事会工作报告" which translates to "2017 Supervisory Board Work Report". It details the supervisory board's activities, including oversight of financial conditions, major asset restructuring, related party transactions, internal controls, and compliance with laws and regulations during the 2017 fiscal year. The report includes references to financial reports and audit opinions but is itself a supervisory board report rather than a full annual report or audit report. The document length is 2383 characters, which is relatively short and focused on supervisory board work rather than comprehensive financial statements. This type of document aligns best with the category of Management Reports (MDA), which covers management's detailed explanation of financial results, business trends, and outlook, including supervisory board reports. It is not an Annual Report (10-K) or Audit Report (AR) because it does not contain full financial statements or standalone audit opinions but rather supervisory oversight commentary. Therefore, the appropriate classification is MDA with high confidence.
2018-04-11 Chinese
第八届监事会第四次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of a company regarding the approval of various reports and proposals related to the 2017 fiscal year, including the 2017 Annual Report, financial statements, Supervisory Board work report, profit distribution plan, appointment of auditors, and amendments to meeting rules. The document repeatedly states that the detailed contents of these reports are disclosed elsewhere on a public information website and that these resolutions will be submitted to the 2017 Annual General Meeting for approval. The document itself does not contain the full annual report or detailed financial statements but is a formal announcement of the Supervisory Board's meeting decisions and approvals. The document length is 2433 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is an official announcement of meeting resolutions and approvals related to the annual report and other documents, but it is not the annual report itself.
2018-04-11 Chinese
2017年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as the 2017 annual report summary of Chengdu Berry Genomics Co., Ltd. It contains detailed financial data for the year 2017, including revenue, net profit, assets, and shareholder information. It discusses the company's business operations, major accounting data, financial indicators, and future development plans. The document is comprehensive and covers the full fiscal year, consistent with an official yearly report. There is no indication that this is merely an announcement or a summary without substantive financial data. Therefore, this document fits the definition of an Annual Report (10-K). FY 2017
2018-04-11 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.